McAllister-Williams, RH;
Baldwin, DS;
Cantwell, R;
Easter, A;
Gilvarry, E;
Glover, V;
Green, L;
... Young, AH; + view all
(2017)
British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017.
Journal of Psychopharmacology
, 31
(5)
pp. 519-552.
10.1177/0269881117699361.
Preview |
Text
Micali MCALLISTER_WILLIAM_Publishedonline25April2017_GREEN_AAM (1).pdf - Accepted Version Download (1MB) | Preview |
Abstract
Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.
| Type: | Article |
|---|---|
| Title: | British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017 |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1177/0269881117699361 |
| Publisher version: | https://doi.org/10.1177/0269881117699361 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Clinical Neurology, Neurosciences, Pharmacology & Pharmacy, Psychiatry, Neurosciences & Neurology, Antidepressants, antipsychotics, anxiolytics, birth defects, breastfeeding, child development, conception, fertility, hypnotics, mood stabilisers, neonatal problems, postpartum, pregnancy, pregnancy outcome, psychiatric illness, psychotropics, teratogenicity, SEROTONIN-REUPTAKE INHIBITORS, POPULATION-BASED COHORT, AUTISM SPECTRUM DISORDER, IN-UTERO EXPOSURE, TRANSCRANIAL MAGNETIC STIMULATION, PERSISTENT PULMONARY-HYPERTENSION, BENZODIAZEPINE-RECEPTOR AGONISTS, PRENATAL ANTIDEPRESSANT EXPOSURE, INTRAUTERINE GROWTH-RETARDATION, DEFICIT HYPERACTIVITY DISORDER |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Population, Policy and Practice Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10062619 |
Archive Staff Only
 |
View Item |
